Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 MMP-9 activities (2005)
- Authors:
- USP affiliated authors: UZUELLI, JULIANA ALVES - FMRP ; MACHADO, ALCYONE ARTIOLI - FMRP ; GERLACH, RAQUEL FERNANDA - FORP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FMRP; FORP
- DOI: 10.1016/j.clinbiochem.2005.02.010
- Assunto: METALOPROTEINASES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Clinical Biochemistry
- ISSN: 0009-9120
- Volume/Número/Paginação/Ano: v. 38, p. 410-414, 2005
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SOUZA-TARLA, Caroline D. et al. Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 MMP-9 activities. Clinical Biochemistry, v. 38, p. 410-414, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.clinbiochem.2005.02.010. Acesso em: 19 set. 2024. -
APA
Souza-Tarla, C. D., Uzuelli, J. A., Machado, A. A., Gerlach, R. F., & Tanus-Santos, J. E. (2005). Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 MMP-9 activities. Clinical Biochemistry, 38, 410-414. doi:10.1016/j.clinbiochem.2005.02.010 -
NLM
Souza-Tarla CD, Uzuelli JA, Machado AA, Gerlach RF, Tanus-Santos JE. Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 MMP-9 activities [Internet]. Clinical Biochemistry. 2005 ; 38 410-414.[citado 2024 set. 19 ] Available from: https://doi.org/10.1016/j.clinbiochem.2005.02.010 -
Vancouver
Souza-Tarla CD, Uzuelli JA, Machado AA, Gerlach RF, Tanus-Santos JE. Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 MMP-9 activities [Internet]. Clinical Biochemistry. 2005 ; 38 410-414.[citado 2024 set. 19 ] Available from: https://doi.org/10.1016/j.clinbiochem.2005.02.010 - Effect of anticoagulantes on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities
- Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma activity in healthy subjects
- A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients
- eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population
- Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism
- Inibição de metaloproteinases (MMPs) com Doxycycline atenua a embolia pulmonar aguda (EPA)-indutor de hipotensão sistêmica
- Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers
- Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism
- Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
- A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism
Informações sobre o DOI: 10.1016/j.clinbiochem.2005.02.010 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas